Switching from Vyvanse to Adderall for ADHD
Yes, switching from Vyvanse (lisdexamfetamine) to Adderall (mixed amphetamine salts) is appropriate and commonly done in clinical practice, as both are first-line stimulant medications for ADHD with similar mechanisms of action. 1
Rationale for Switching
Switching between ADHD stimulants is frequently indicated and represents standard practice rather than an exception. 1 Common reasons include:
- Inadequate symptom control despite appropriate dosing and duration of the current medication 1
- Unacceptable side effects such as decreased appetite, insomnia, irritability, or cardiovascular effects 1, 2
- Duration of effect mismatch with daily functional needs (Vyvanse typically lasts 13-14 hours; Adderall IR lasts 4-6 hours; Adderall XR lasts 10-12 hours) 1, 2
- Cost or insurance coverage issues, which are legitimate practical considerations in day-to-day practice 1
Pharmacologic Considerations
Both medications work through the same mechanism—they are amphetamine-based stimulants that inhibit reuptake and promote release of dopamine and norepinephrine. 1 The key difference is that Vyvanse is a prodrug requiring conversion to active d-amphetamine in the body, while Adderall contains a mixture of amphetamine salts (75% dextroamphetamine and 25% levoamphetamine) that are immediately active. 2, 3
Switching Strategy
Direct switch (abrupt transition) is the most practical approach for switching between these two amphetamine-based stimulants:
- Stop Vyvanse and start Adderall the next day at an equivalent dose 1
- No washout period is required because both medications have similar mechanisms and short half-lives 1
- Approximate dose conversion: 30 mg Vyvanse ≈ 10 mg Adderall; 50 mg Vyvanse ≈ 15-20 mg Adderall; 70 mg Vyvanse ≈ 20-30 mg Adderall 2, 3
Dosing Recommendations
- Adderall IR: Start with 5-10 mg once or twice daily (morning and midday), titrate in 5-10 mg increments weekly as needed 1
- Adderall XR: Start with 10-20 mg once daily in the morning, titrate in 5-10 mg increments weekly up to maximum 50 mg daily 4
- Timing: Administer in the morning (and early afternoon for IR formulations) to minimize insomnia 1, 4
Monitoring During Transition
Monitor closely during the first 1-2 weeks for:
- Common side effects: Decreased appetite, insomnia, irritability, headache, upper abdominal pain 1, 2
- Cardiovascular effects: Blood pressure and heart rate changes 1, 4
- Symptom control: ADHD symptom improvement throughout the day 1, 2
- Rebound symptoms: Potential for symptom return in afternoon/evening, particularly with shorter-acting formulations 1
Important Caveats
- Both are Schedule II controlled substances with abuse potential, though Vyvanse's prodrug formulation theoretically confers lower abuse liability 2, 3
- Avoid in patients with: Uncontrolled hypertension, coronary artery disease, tachyarrhythmias, or active substance use disorders 1
- Consider methylphenidate-based medications (Ritalin, Concerta) as alternatives if amphetamine side effects are problematic, as they have different mechanisms and side effect profiles 1, 5
- Dose adjustments are the rule, not the exception in ADHD management—expect to titrate based on response and tolerability 1